Syngene is a publicly listed subsidiary whose core capabilities include highly effective problem-solving and scientific innovation, allied to a clear commitment to safety, quality, and operating excellence. It takes an integrated approach to the disciplines of discovery, development and manufacturing of novel molecules to ensure a quality project delivery on time, every time – all with a single-minded commitment to turning clients’ ideas into meaningful innovation.